Search research articles
Contact Us
Filters
Showing results (171-180 of 191) with videos related to
Page
of 20
Sort By:
Molecular & Cellular Proteomics : MCP
|
December 7, 2007
Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses
Anthony O Gramolini, Thomas Kislinger, Rasoul Alikhani-Koopaei, et al.
Breast Cancer Research and Treatment
|
April 2, 2025
Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial
Wonyoung Jung, Rebecca A Hubbard, Amanda M Smith, et al.
European Journal of Heart Failure
|
September 2, 2008
State of the art: using natriuretic peptide levels in clinical practice
Alan Maisel, Christian Mueller, Kirkwood Adams, et al.
JAMA Network Open
|
December 3, 2025
Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial
Congying Xia, Amanda M Smith, Bénédicte Lefebvre, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 11, 2018
Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update
Sheldon W Tobe, James A Stone, Todd Anderson, et al.
Circulation Research
|
August 4, 2007
Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload
Keiji Kuba, Liyong Zhang, Yumiko Imai, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 5, 2020
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
Feng Zhou, Ye-Mao Liu, Jing Xie, et al.
American Heart Journal
|
May 26, 2009
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group
Mihai Gheorghiade, Kirkwood F Adams, John G F Cleland, et al.
Circulation. Heart Failure
|
March 18, 2010
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward
G Michael Felker, Peter S Pang, Kirkwood F Adams, et al.
The Canadian Journal of Cardiology
|
April 5, 2011
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group
, Lawrence A Leiter, David H Fitchett, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 191) with videos related to
Sort By:
Page
of 20
Molecular & Cellular Proteomics : MCP
|
December 7, 2007
Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses
Anthony O Gramolini, Thomas Kislinger, Rasoul Alikhani-Koopaei, et al.
Breast Cancer Research and Treatment
|
April 2, 2025
Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial
Wonyoung Jung, Rebecca A Hubbard, Amanda M Smith, et al.
European Journal of Heart Failure
|
September 2, 2008
State of the art: using natriuretic peptide levels in clinical practice
Alan Maisel, Christian Mueller, Kirkwood Adams, et al.
JAMA Network Open
|
December 3, 2025
Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial
Congying Xia, Amanda M Smith, Bénédicte Lefebvre, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 11, 2018
Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update
Sheldon W Tobe, James A Stone, Todd Anderson, et al.
Circulation Research
|
August 4, 2007
Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload
Keiji Kuba, Liyong Zhang, Yumiko Imai, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 5, 2020
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
Feng Zhou, Ye-Mao Liu, Jing Xie, et al.
American Heart Journal
|
May 26, 2009
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group
Mihai Gheorghiade, Kirkwood F Adams, John G F Cleland, et al.
Circulation. Heart Failure
|
March 18, 2010
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward
G Michael Felker, Peter S Pang, Kirkwood F Adams, et al.
The Canadian Journal of Cardiology
|
April 5, 2011
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group
, Lawrence A Leiter, David H Fitchett, et al.
Page
of 20